| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/29/1994 | US5298514 Phenolic thioetheramides |
| 03/29/1994 | US5298513 Serotonin antagonist |
| 03/29/1994 | US5298512 Substituted chromans and their use in the treatment of asthma, arthritis and related diseases |
| 03/29/1994 | US5298511 Alkanoic acid derivatives |
| 03/29/1994 | US5298510 Medicaments |
| 03/29/1994 | US5298506 Use of guanylate cyclase inhibitors in the treatment of shock |
| 03/29/1994 | US5298505 Ethynyl alanine amino diol compounds having a piperazinyl-terminated group or a piperazinyl-alkylamino-terminated group for treatment of hypertension |
| 03/29/1994 | US5298504 Pyridostigmine, diazepam orclonazepam and arnepal, sycotrol, caramiphen or benactyzine |
| 03/29/1994 | US5298503 Cardiovascular |
| 03/29/1994 | US5298502 Method and composition for photodynamic treatment and detection of tumors |
| 03/29/1994 | US5298498 Phosphonic acid derivatives useful as anti-inflammatory agents |
| 03/29/1994 | US5298497 Method for preventing onset of hypertension employing a cholesterol lowering drug |
| 03/29/1994 | US5298496 Inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer, process for the preparation thereof, and pharmaceutical compositions containing the same |
| 03/29/1994 | US5298495 Partricin derivatives |
| 03/29/1994 | US5298422 Myogenic vector systems |
| 03/29/1994 | US5298397 Reacting liqid phase with solid phase containg antibody, separation of phases, measuring bind antibody to solid phase |
| 03/29/1994 | US5298258 Acrylic oily gel bioadhesive material and acrylic oily gel preparation |
| 03/29/1994 | US5298257 Controlled transdermal nicotine delivery; anti-irritant |
| 03/29/1994 | US5298249 Compositions comprising N-hydroxyquinazolinone and 2-N-hydroxythiourea benzoate compounds as biocides |
| 03/29/1994 | US5298248 Introducing vitamin into water and vitamin impermeable receptacle, closing aperture with permeable membrane, immersing receptacle in well for diffusion of vitamin |
| 03/29/1994 | US5298242 Skin microbiocides or preservatives |
| 03/29/1994 | US5298222 Process for disinfecting musculoskeletal tissue and tissues prepared thereby |
| 03/29/1994 | US5298018 Method for treating cardiovascular disease through adjunctive photodynamic therapy |
| 03/29/1994 | US5297562 Method for detecting and treating Alzheimer's disease |
| 03/29/1994 | CA2107180A1 Biotin amides, a process for their preparation and therapeutical compositions containing them as the active principles for the treatment of diabetes and relative complicating diseases |
| 03/29/1994 | CA2107061A1 Piperidine derivatives, their preparation and their application in therapy |
| 03/29/1994 | CA2107060A1 Piperidine derivatives, their preparation and their application in therapeutics |
| 03/29/1994 | CA2106141A1 Antibiotic compounds |
| 03/29/1994 | CA2099427A1 Indications for carnitine |
| 03/29/1994 | CA1328113C Process for the manufacture of novel unsaturated amino acid compounds |
| 03/29/1994 | CA1328109C Hydroxybutenolide derivatives, production and use thereof |
| 03/29/1994 | CA1328106C Anticholinergic compounds, pharmaceutical compositions and method of treatment |
| 03/29/1994 | CA1328105C Derivatized alkanolamines as cardiovascular agents |
| 03/29/1994 | CA1328104C 24r-scymnol, and preparation and use thereof |
| 03/29/1994 | CA1328081C2 Antibacterial antiplaque, anticalculus oral composition |
| 03/29/1994 | CA1328079C Treatment of hypertension by chronic administration of tryptophan |
| 03/29/1994 | CA1328078C Aqueous formulations containing a piperidinylcyclopentylheptenoic acid derivative |
| 03/29/1994 | CA1328077C Antipsychotic compositions containing dioxopiperidine derivatives |
| 03/29/1994 | CA1328076C Cerebral hyperkinemic composition containing a dihydropyridine derivative |
| 03/29/1994 | CA1328075C Ocular hypotensive agents |
| 03/26/1994 | CA2106892A1 5-oxo-dibenzo(a,d)cyclohepta-1,4-dienes |
| 03/26/1994 | CA2106840A1 Heteroarylazetidines and -pyrrolidines, process for their preparation and pharmaceutical compositions containing them |
| 03/26/1994 | CA2106822A1 7-(aminomethyl-oxa-7-aza-bicyclo(3.3.0)oct-7-yl) quinolonecarboxylic and 7-(aminomethyl-oxa- 7-aza-bicyclo(3.3.0)oct-7-yl) naphthyridonecarboxylic acid derivatives |
| 03/26/1994 | CA2106716A1 Process for preparing 4-hydroxypyrrolo(2,3-d) pyrimidine based antifolate compounds and intermediates |
| 03/26/1994 | CA2106630A1 Process for preparing 5-substituted pyrrolo-[2,3-d]pyrimidine intermediates |
| 03/26/1994 | CA2104748A1 Hydroxyphosphinyl phosphonate squalene synthetase inhibitors and method |
| 03/25/1994 | CA2106818A1 N1-substituted 1h-1,2,3-triazolo [4,5-d]pyrimidines, a process for their preparation and their use as antiviral agents |
| 03/25/1994 | CA2106034A1 21-norrapamycin |
| 03/24/1994 | DE4231675A1 Glycopeptide adjuvant for increasing antibody prodn. - formulated as optimised dose for dissolving in aq. antigen soln., more active than Freund's adjuvant and requires no oil emulsion |
| 03/24/1994 | DE4231289A1 Neuer Naturstoff Cyclamenol und chemische Derivate New natural product cyclamenol and chemical derivatives |
| 03/24/1994 | DE4229805A1 Treating diseases caused by prion proteins or analogues - with calcium channel antagonists or NMDA antagonists, having cytoprotective effect on brain neurons |
| 03/24/1994 | CA2105595A1 Antisense polynucleotides |
| 03/23/1994 | EP0588762A1 Use of pyrimidine derivatives as inhibitors of proteinkinase C and antitumor drugs |
| 03/23/1994 | EP0588655A1 Amidinophenol derivatives |
| 03/23/1994 | EP0588621A2 Neutral lipids from endosperm of job's tears and compositions including them |
| 03/23/1994 | EP0588539A1 Stabilized pharmaceutical compositions containing derivatives of vitamins D2 and D3 |
| 03/23/1994 | EP0588518A1 Use of 2-(3,4-dimethoxycinnamoyl)-aminobenzoic acid for the manufacture of a medicament for the treatment of restenosis |
| 03/23/1994 | EP0588500A2 3-Oxadiazolyl-1,6-naphthyridine derivatives with affinity for benzodiazepine receptors |
| 03/23/1994 | EP0588430A1 (S)-(+)-Hydroxychloroquine |
| 03/23/1994 | EP0588379A2 Treatment of wrinkling |
| 03/23/1994 | EP0588317A1 Uridine derivative and process for preparing the same |
| 03/23/1994 | EP0588229A2 Macrocyclic chelating agents for the preparation of Technetium or Rhenium complexes |
| 03/23/1994 | EP0588166A2 Antibacterial 7-isoindolinyl-quinolone and naphthyridone derivatives |
| 03/23/1994 | EP0588137A1 3-Aryl-2-pyranone derivatives |
| 03/23/1994 | EP0587972A1 Sports drink without added sugar or artificial sweetener |
| 03/23/1994 | EP0587823A1 Using the immunoactivating activity of 3-naphthyloxy-2-hydroxy-propylamines, in particular for providing cell immunity, e.g. against viral infections |
| 03/23/1994 | EP0587815A1 Hypertonic isochloremic formulation for circulatory shock |
| 03/23/1994 | EP0587814A1 Substituted pyrimidinones bearing acidic functional groups as angiotensin ii antagonists |
| 03/23/1994 | EP0587800A1 Immunomodulatory azaspiranes |
| 03/23/1994 | EP0587789A1 Methods of treating injury to the central nervous system |
| 03/23/1994 | EP0587770A1 Platelet receptor antagonists useful in detecting intravascular platelet aggregation |
| 03/23/1994 | EP0587767A1 Hydroxyazido derivatives and related compounds as renin inhibitors |
| 03/23/1994 | EP0587756A1 Novel immunosuppressive compounds |
| 03/23/1994 | EP0587751A1 Therapeutic compositions for osteoinduction |
| 03/23/1994 | EP0587749A1 Compositions and delivery systems for transdermal administration of neutral oligomers |
| 03/23/1994 | EP0587698A1 Substituted 1-(2h)-isoquinolinones bearing acidic functional groups as angiotensin ii antagonists |
| 03/23/1994 | EP0587673A1 Derivatives of thiopyranopyrrole and preparation thereof |
| 03/23/1994 | EP0587670A1 Pcp receptor ligands and the use thereof |
| 03/23/1994 | EP0587645A1 Benzo- and pyridopyran derivatives having anxiolytic and anti-convulsant activity |
| 03/23/1994 | EP0587577A1 Compounds and method for protection of cells and tissues from irreversible injury due to lactic acidosis |
| 03/23/1994 | EP0504236B1 Utilisation of extracts of algae for the preparation of pharmaceutical, cosmetic, food or agricultural compositions |
| 03/23/1994 | EP0502032B1 Delayed release formulations |
| 03/23/1994 | EP0495009A4 Diagnostic kit and diagnostic method utilizing carbohydrate receptors |
| 03/23/1994 | EP0433360B1 Improvements relating to the production of prodrugs |
| 03/23/1994 | EP0416014B1 Liposome-encapsulated vinca alkoaloids and their use in combatting tumors |
| 03/23/1994 | EP0393109B1 Novel 2,3-thiomorpholinedione-2-oxime derivatives, pharmaceutical compositions containing them and process for preparing same |
| 03/23/1994 | CN1084178A 2'-deoxy-2'-2'-difluoro(2,6,8-substituted) purine nucleosides having anti-viral and anti-cancer activity and intermediates |
| 03/23/1994 | CN1084177A 2'-deoxy-2',2'-difluoro(4-substituted pyrimidine) nucleosides having anti-viral and anti-cancer activity and intermediates |
| 03/23/1994 | CN1084175A Novel phospholipid derivatives |
| 03/23/1994 | CN1084174A Method of preparation of physostigmine carbamate derivatives from physostigmine |
| 03/23/1994 | CN1084173A 1-AzabicycloÛ3.2.0Ùhept-2-ene-2-carboxylic acid derivatives and their preparation |
| 03/23/1994 | CN1084172A Thiadiazinones |
| 03/23/1994 | CN1084169A Compounds |
| 03/23/1994 | CN1084166A Substituted (benzothiazolyl-and quinoxalyl-methoxy) phenyl-acetic acid derivatives |
| 03/23/1994 | CN1084162A Octahydronaphthalene oxime derivatives for cholesterol biosynthesis inhibition, their preparation and use |
| 03/23/1994 | CN1084078A External use antithyroid cream |
| 03/23/1994 | CN1084064A Formulations containing hyaluronic acid |
| 03/23/1994 | CN1084062A Composition for treating pain, method for treaing pain and composition for reinforcing pain relief action |
| 03/23/1994 | CN1084061A Agent for treating cataract and method for its preparation |
| 03/23/1994 | CN1084010A Treatment of diseas of shrimp |